Infographics

Pregnancy in Adult Congenital Heart Disease (ACHD)

Pregnancy in Adult Congenital Heart Disease (ACHD) This infographic provides a comprehensive overview of considerations for managing pregnancy in women with adult congenital heart disease (ACHD). It outlines each stage of pregnancy from preconception to postpartum, focusing on risk assessment, monitoring, and collaborative care with cardio-obstetrics. Key advice includes preconception…

Continue ReadingPregnancy in Adult Congenital Heart Disease (ACHD)

Approach to Diuretic Resistance

Approach to Diuretic Resistance This infographic outlines the mechanisms and management strategies for addressing diuretic resistance in patients, including approaches based on pharmacology, extra-renal, and intra-renal factors. Key management recommendations are included for sequential blockade, acetazolamide, high-dose mineralocorticoid receptor antagonists, hypertonic saline, and SGLT-2 inhibitors Produced by: Dr. Gurleen KaurEdited…

Continue ReadingApproach to Diuretic Resistance

Causes of Hypertriglyceridemia

Causes of Hypertriglyceridemia This infographic provides an overview of hypertriglyceridemia, the most common dyslipidemia affecting about 30% of the population. Hypertriglyceridemia often begins at levels of ≥150 mg/dl, though even high-normal values (100-140 mg/dl) may carry increased cardiovascular risk. Key causes are summarized with the mnemonic "High Lipids Cause Morbidity":…

Continue ReadingCauses of Hypertriglyceridemia

Anticoagulation for Atrial Fibrillation/Flutter

Anticoagulation for Atrial Fibrillation/Flutter This infographic outlines a step-by-step guide for considering anticoagulation in patients with atrial fibrillation or atrial flutter. Key steps include confirming the diagnosis, calculating the CHA₂DS₂-VASc and HAS-BLED scores, and involving patients in shared decision-making. Warfarin and various DOACs are listed with indications for dosage and…

Continue ReadingAnticoagulation for Atrial Fibrillation/Flutter

Ischemia and Non-Obstructive Coronary Artery Disease (INOCA)

INOCA: Ischemia and Non-Obstructive Coronary Artery Disease Summary:INOCA refers to symptoms of ischemia without obstructive coronary artery disease (CAD) or flow-limiting disease on left heart catheterization. The prevalence is significant, affecting 3-4 million people in the US, with around 70% of anginal hospitalizations showing non-obstructive CAD findings. It predominantly impacts…

Continue ReadingIschemia and Non-Obstructive Coronary Artery Disease (INOCA)

Bleeding Academic Research Consortium (BARC) Scale

Bleeding Academic Research Consortium (BARC) Scale Summary:The BARC Scale is a standardized tool used to categorize and define bleeding events in clinical trials. It spans from Type 1, which includes minor bleeding events that do not require medical intervention, to Type 5, indicating fatal bleeding. This scale helps clinicians assess…

Continue ReadingBleeding Academic Research Consortium (BARC) Scale

End of content

No more pages to load